OMEGA THERAPEUTICS INC. - COMMON STOCK

1,1400

12-ноября-24 15:45:00

15 мин. задержка

Акции

+0,0500

+4,59%

Сегодняшний диапазон

1,0700 - 1,1550

ISIN

N/A

Источник

NASDAQ

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

15 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications

17 сен 2024 06:00:02 Источник Nasdaq GlobeNewswire
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

14 авг 2024 06:00:08 Источник Nasdaq GlobeNewswire
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

06 авг 2024 06:00:09 Источник Nasdaq GlobeNewswire
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

24 июн 2024 06:00:53 Источник Nasdaq GlobeNewswire
Omega Therapeutics To Participate In Two Upcoming Investor Conferences

30 май 2024 06:00:59 Источник Nasdaq GlobeNewswire
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

29 май 2024 06:00:17 Источник Nasdaq GlobeNewswire
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

08 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

06 май 2024 06:00:02 Источник Nasdaq GlobeNewswire
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

23 апр 2024 06:00:02 Источник Nasdaq GlobeNewswire
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control

09 апр 2024 06:00:31 Источник Nasdaq GlobeNewswire
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

28 мар 2024 08:15:05 Источник Nasdaq GlobeNewswire
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

06 мар 2024 06:00:08 Источник Nasdaq GlobeNewswire
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 янв 2024 15:05:13 Источник Nasdaq GlobeNewswire
Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

04 дек 2023 15:00:22 Источник Nasdaq GlobeNewswire
Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference

20 ноя 2023 15:00:00 Источник Nasdaq GlobeNewswire
Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis

13 ноя 2023 06:00:32 Источник Nasdaq GlobeNewswire
Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

09 ноя 2023 06:00:17 Источник Nasdaq GlobeNewswire
Omega Therapeutics to Participate in The Jefferies London Healthcare Conference

07 ноя 2023 15:00:20 Источник Nasdaq GlobeNewswire
Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller

31 окт 2023 06:00:16 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.